Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 291 entries
View as:

Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01510288 Org: User:
Start: 11/30/04 End: 11/30/11 Due: 11/30/12

Gaining Insight Into Dual Sensory Loss

Phase: N/A Priority: Normal
NCT ID: NCT06362213 Org: User:
Start: 04/15/24 End: 04/30/25 Due: 04/30/26

Predictive Factors for Succes of ITB in CP

Phase: N/A Priority: Normal
NCT ID: NCT05817409 Org: User:
Start: 06/01/23 End: 12/01/27 Due: 12/01/28

Registry of Patients That Have Undergone ICA or PCI

Phase: N/A Priority: Normal
NCT ID: NCT04815928 Org: User:
Start: 07/01/20 End: 07/01/35 Due: 07/01/36

BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02054845 Org: User:
Start: 01/31/14 End: 12/31/14 Due: 12/31/15

Time to Protein Target Using a High Whey Protein Enteral Nutrition in Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT02815527 Org: User:
Start: 03/31/16 End: 09/30/17 Due: 09/30/18

Peritoneum Vaginoplasty; Implementation According to IDEAL Framework

Phase: N/A Priority: Normal
NCT ID: NCT05925361 Org: User:
Start: 05/25/23 End: 03/01/25 Due: 03/01/26

Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

Phase: N/A Priority: Normal
NCT ID: NCT06567197 Org: User:
Start: 08/25/23 End: 09/01/28 Due: 09/01/29

the PRECious Trial: PREdiction of Complications

Phase: N/A Priority: Normal
NCT ID: NCT02102217 Org: User:
Start: 12/31/15 End: 09/30/20 Due: 09/30/21

The Day-time Response Variation of (Lis)Dexamphetamine

Phase: N/A Priority: Normal
NCT ID: NCT04946461 Org: User:
Start: 07/01/21 End: 06/16/22 Due: 06/16/23

Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05088785 Org: User:
Start: 10/11/21 End: 04/30/25 Due: 04/30/26

PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG

Phase: N/A Priority: Normal
NCT ID: NCT03805048 Org: User:
Start: 01/22/19 End: 06/30/28 Due: 06/30/29

Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03573596 Org: User:
Start: 02/01/18 End: 02/01/24 Due: 02/01/25

Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02130726 Org: User:
Start: 12/31/14 End: 06/30/19 Due: 06/30/20

Rate Adaptive Atrial Pacing in Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03235843 Org: User:
Start: 08/01/17 End: 12/01/19 Due: 12/01/20

Perioperative Temperature Management

Phase: N/A Priority: Normal
NCT ID: NCT00617136 Org: User:
Start: 04/30/08 End: 01/31/12 Due: 01/31/13

Evaluating PVI Using CMR

Phase: N/A Priority: Normal
NCT ID: NCT05437549 Org: User:
Start: 07/01/22 End: 07/01/24 Due: 07/01/25

Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05350722 Org: User:
Start: 08/24/22 End: 12/31/37 Due: 12/31/38

Early Biomarker With 18F-FDG PET for Treatment Optimization of Anti-EGFR Therapy in Patients With Metastatic Colorectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01691391 Org: User:
Start: 01/31/12 End: 11/03/20 Due: 11/03/21

Nilotinib Plus Pegylated Interferon-α2b in CML

Phase: N/A Priority: Normal
NCT ID: NCT01866553 Org: User:
Start: 04/30/13 End: 05/01/16 Due: 05/01/17

89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT05955833 Org: User:
Start: 06/26/23 End: 04/30/24 Due: 04/30/25

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Phase: N/A Priority: Normal
NCT ID: NCT05834855 Org: User:
Start: 04/30/23 End: 05/31/27 Due: 05/31/28

Microvascular Dysfunction and the Development of Whole-body Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT02628301 Org: User:
Start: 04/30/15 End: 05/30/17 Due: 05/30/18

Capturing Readmission Internationally to Prevent Readmission by Safer@Home Group

Phase: N/A Priority: Normal
NCT ID: NCT02621723 Org: User:
Start: 01/31/16 End: 01/31/18 Due: 01/31/19

Counting Steps! Integration of Objectively Assessed Physical Activity and Fitness With Smartphones in Clinical Oncology Practice.

Phase: N/A Priority: Normal
NCT ID: NCT03493672 Org: User:
Start: 10/18/17 End: 02/01/20 Due: 02/01/21